GSK-812397

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C24H32N6O
Molecular Weight	420.5505
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN(CC1=C(CO)N2C(C=CC=C2N3CCN(C)CC3)=N1)[C@H]4CCCC5=C4N=CC=C5

InChI

InChIKey=QUDMHFVRKBVGBY-FQEVSTJZSA-N

InChI=1S/C24H32N6O/c1-27-12-14-29(15-13-27)23-10-4-9-22-26-19(21(17-31)30(22)23)16-28(2)20-8-3-6-18-7-5-11-25-24(18)20/h4-5,7,9-11,20,31H,3,6,8,12-17H2,1-2H3/t20-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C24H32N6O
Molecular Weight	420.5505
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

PubMed

Title	Date	PubMed
Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist.	2010 Feb	19949058

Substance Class	Chemical Created by `admin` on `Sat Dec 16 18:26:20 GMT 2023` Edited by `admin` on `Sat Dec 16 18:26:20 GMT 2023`
Record UNII	966F77521M
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GSK-812397

Common Name

English

IMIDAZO(1,2-A)PYRIDINE-3-METHANOL, 5-(4-METHYL-1-PIPERAZINYL)-2-((METHYL((8S)-5,6,7,8-TETRAHYDRO-8-QUINOLINYL)AMINO)METHYL)-

Systematic Name

English

(5-(4-METHYL-1-PIPERAZINYL)-2-((METHYL((8S)-5,6,7,8-TETRAHYDRO-8-QUINOLINYL)AMINO)METHYL)IMIDAZO(1,2-A)PYRIDIN-3-YL)METHANOL

Systematic Name

English

Code System Code Type Description

FDA UNII

966F77521M

Created by admin on Sat Dec 16 18:26:20 GMT 2023 , Edited by admin on Sat Dec 16 18:26:20 GMT 2023

PRIMARY

CAS

878197-98-9

Created by admin on Sat Dec 16 18:26:20 GMT 2023 , Edited by admin on Sat Dec 16 18:26:20 GMT 2023

PRIMARY

PUBCHEM

11718722

Created by admin on Sat Dec 16 18:26:20 GMT 2023 , Edited by admin on Sat Dec 16 18:26:20 GMT 2023

PRIMARY

Related Record Type Details


					966F77521M

GSK-812397

ACTIVE MOIETY